Leads Biolabs - Crunchbase Company Profile & Funding

Q: Where is Leads Biolabs's headquarters?

Leads Biolabs is located in Nanjing, Jiangsu, China.

Q: Who invested in Leads Biolabs?

Leads Biolabs has 24 investors including Anjie Zhengjuan And New Hope Finance.

Q: When was the last funding round for Leads Biolabs?

Leads Biolabs closed its last funding round on obfuscated from a Series C round.

Q: How much funding has Leads Biolabs raised to date?

Leads Biolabs has raised obfuscated.

Overview

Leads Biolabs

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Leads Biolabs

CB Rank

21329

Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide.

Founded

obfuscation

Public

Series C

Nanjing, Jiangsu, China

101-250

www.leadsbiolabs.com

Biotechnology

Health Care

Pharmaceutical

Funding Rounds

Series C

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Key People

Xiaoqiang Kang: Founder, President, Chairman
Ling Hong: Senior Vice President and Chief Scientific Officer

Details

Legal Name

南京维立志博生物科技有限公司

Operating Status

Active

Stock Symbol

HKG:9887

Company Type

For Profit

Founders

Lai Shoupeng, Xiaoqiang Kang

About the Company

Leads Biolabs is a biotechnology company that develops treatment outcomes and access for patients worldwide. The company is committed to researching and developing novel antibody-based therapeutics in oncology and immunological disease areas in order to meet patients' global unmet needs. On the monoclonal antibody and bispecific antibody

development technology platform, they already have a robust research and development pipeline with over ten innovative cancer immunotherapy antibody projects.

Leads Biolabs was founded in 2014 and is headquartered in China.

Phone Number

025-83378099

Contact Email

wlzb@leadsbiolabs.com

Predictions & Insights

Growth Insight

See this Growth Insight

Leads Biolabs is

Lorem

to be growing

Top Contributing Factors

Operations Expansion

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

LBL-007

A fully human monoclonal antibody targeting LAG-3 to block its interaction and restore T cell immune function for cancer treatment.

LBL-024

A bispecific antibody targeting PD-L1 and 4-1BB to block immune suppression and activate T cells for anti-tumor effects.

Research & Development

Leads Biolabs is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C
obfuscated obfuscation	Series C - Leads Biolabs	13	obfuscated obfuscation	Loyal Valley Capital	Series C

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Anjie Zhengjuan	—	Series C - Leads Biolabs	—
Anjie Zhengjuan	—	Series C - Leads Biolabs	—
Anjie Zhengjuan	—	Series C - Leads Biolabs	—
Anjie Zhengjuan	—	Series C - Leads Biolabs	—
Anjie Zhengjuan	—	Series C - Leads Biolabs	—